[Source: Research & Innovation]
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money – and lead to safer drugs reaching patients faster.
08
Jun
Research Headlines – A faster way to spot the tell-tale signs of cancer-causing drugs
Leave a Reply
You must be logged in to post a comment.